Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

XFIV vs XTRE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

XTRE Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

XTRE Overall Winner 6-Pillar Tally: XFIV 0 – 0 XTRE (6 Tie) Matrix Metrics: XFIV 1 – 2 XTRE

As of Nov 16, 2026, BondBloxx Bloomberg Three Year Target Duration US Treasury ETF (XTRE) is the stronger overall head-to-head candidate over BondBloxx Bloomberg Five Year Target Duration US Treasury ETF (XFIV) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). XFIV carries a Unified Composite Score of 45.1/100 (HOLD) at $46.98 (N/M Forward P/E, N/A operating margin), whereas XTRE carries 46.9/100 (HOLD) at $48.00 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: XFIV is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.2); meanwhile XTRE is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About XFIV vs XTRE
XFIV NYSE Arca
BondBloxx Bloomberg Five Year Target Duration US Treasury ETF
Institutional Equity
$46.98
+0.26% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.08β · 5% Vol
Unified Composite Score
45.1 / 100 HOLD
Tech 48.0 Fund 51.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.7%) with fading momentum, RSI 43
RSI-14: 43.2 · SMA20: $47.28 · SMA50: $47.08
XTRE NYSE Arca Head-to-Head Winner
BondBloxx Bloomberg Three Year Target Duration US Treasury ETF
Institutional Equity
$48.00
+0.17% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.04β · 4% Vol
Unified Composite Score
46.9 / 100 HOLD
Tech 49.0 Fund 54.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.5%) with fading momentum, RSI 44
RSI-14: 43.6 · SMA20: $48.18 · SMA50: $48.07

6-Pillar Scorecard Institutional Category Breakdown (XFIV 0 – 0 XTRE)

Columns: Metric · XFIV · XTRE
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Distribution
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: XFIV (1) vs XTRE (2)
Institutional Metric XFIV XTRE Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
14% ($46–$50) 12% ($48–$50) Stronger Trend XFIV
Beta / 30D Volatility
Risk Regime
0.08β · 5% Vol 0.04β · 4% Vol Lower Realized Risk XTRE
Unified Institutional Score
Composite Signal
45.1 / 100 (HOLD) 46.9 / 100 (HOLD) Higher Composite XTRE
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon Tie
XFIV: -0.18% · XTRE: -0.19%
3M Horizon XTRE +0.83 pp
XFIV: -2.49% · XTRE: -1.66%
6M Horizon XTRE +0.84 pp
XFIV: -2.85% · XTRE: -2.01%
1Y Horizon XTRE +1.68 pp
XFIV: -5.24% · XTRE: -3.56%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XFIV vs XTRE. Trailing 12-month operating profitability (XFIV N/A vs XTRE N/A) and valuation multiples (XFIV N/M vs XTRE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

XFIV ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
XTRE ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
XFIV UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact XFIV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
XTRE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact XTRE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
XFIV Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
XTRE Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ XFIV vs XTRE Key Questions & Quantitative Answers

As of Nov 16, 2026, BondBloxx Bloomberg Three Year Target Duration US Treasury ETF (XTRE) is the stronger overall head-to-head candidate over BondBloxx Bloomberg Five Year Target Duration US Treasury ETF (XFIV) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). XFIV carries a Unified Composite Score of 45.1/100 (HOLD) at $46.98 (N/M Forward P/E, N/A operating margin), whereas XTRE carries 46.9/100 (HOLD) at $48.00 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: XFIV is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.2); meanwhile XTRE is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

XFIV and XTRE split Growth & Scale metrics: XFIV posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with XTRE at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, XFIV generates N/A in USD-normalized revenue versus N/A for XTRE. In operating R&D and SG&A reinvestment, XFIV deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for XTRE.

XFIV and XTRE trade at balanced relative valuation multiples. XFIV trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas XTRE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against XFIV (N/A ROE) versus XTRE (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, XFIV carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.08β · 5% Vol realized risk). By comparison, XTRE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.04β · 4% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

BondBloxx Bloomberg Five Year Target Duration US Treasury ETF (XFIV) Research Suite

BondBloxx Bloomberg Three Year Target Duration US Treasury ETF (XTRE) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.